NextCure, Inc. Reports Q3 2026 Financial Results

What Happened

• NextCure, Inc. announced its financial results for the quarter ended June 30, 2026 by issuing a press release dated August 6, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K (Item 2.02: Results of Operations and Financial Condition) filed on August 6, 2026.

Key Details

• Filing date: August 6, 2026 (8-K furnished to the SEC).
• Reporting period: Quarter ended June 30, 2026.
• Exhibit included: Press release (Exhibit 99.1) and Cover Page Interactive Data File (inline XBRL, Exhibit 104).
• Item reported: 2.02 (results of operations and financial condition); 9.01 lists the exhibits.

Why It Matters

• The press release contains the company’s latest quarterly earnings and other financial metrics investors use to assess performance (revenue, net income/loss, cash position, and any guidance). Reviewing the attached release and the inline XBRL lets investors see the reported numbers and compare them with prior quarters.
• Because the company furnished (rather than “filed”) the press release under Item 2.02, investors should read the exhibit itself for the specific figures and management commentary.